Home » Authors » Jim Shrine

Articles by Jim Shrine

Precision Therapeutics slates IPO for personalized platform

Aug. 30, 2007

PDL Selling Cardio Programs, Ending Pivotal Nuvion Trials

Aug. 30, 2007

PDL Selling Cardio Programs, Ending Pivotal Nuvion Trials

Aug. 30, 2007

Indevus Files For FDA Approval For Long-Acting Testosterone

Aug. 29, 2007

Indevus Files For FDA Approval For Long-Acting Testosterone

Aug. 29, 2007

Upstream Completes Acquisition Of Firm Focused On Parasites

Aug. 28, 2007

Precision Therapeutics plans IPO for personalized platform

Aug. 28, 2007

Upstream Completes Acquisition Of Firm Focused On Parasites

Aug. 28, 2007

Precision Therapeutics Plans IPO For Personalized Platform

Aug. 27, 2007

Precision Therapeutics Plans IPO For Personalized Platform

Aug. 27, 2007

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...